Background Recent rapid advances in molecular biology have led the discovery of disease-specific novel fusion genes in a variety of soft tissue tumors. In this study, we attempted to detect these fusion genes using formalin-fixed paraffin-embedded (FFPE) tumor tissues and investigated their clinical utility and factors that affect the results of examination. Methods Reverse transcription polymerase chain reaction for the detection of tumor-specific fusion genes was performed using 41 FFPE tumor samples obtained from 37 patients representing nine histological types of soft tissue tumors that were diagnosed from 2006 to 2017 in our laboratory. Results Fusion genes in 19 (51.3%) out of 37 cases were detected successfully. Relatively high detection rates were observed in synovial sarcomas (100%, 4/4) and alveolar rhabdomyosarcomas (75%, 3/4). The detection rates of fusion genes were inversely correlated with the storage period of FFPE blocks. Decalcification by Plank-Rychlo solution significantly affected detection rates of the internal control gene (P = 0.0038). In contrast, there was no significant difference in detection rates between primary and metastatic lesion, or biopsy and resection material, or presence and absence of treatment history. Conclusion In certain histological types, detection of disease-specific fusion genes of soft tissue tumors using FFPE tissues showed high sensitivity and thus had diagnostic utility. However, due to the diversity of fusion patterns and the low-quality of nucleic acid, the detection rate as a whole was sluggish and required further improvement. For factors affecting the detection results, our results suggested that it was impossible to detect fusion genes by decalcified FFPE tissues, but it may be not necessary to consider factors such as the type of specimen (biopsy or resection) and treatment history of the patients when selecting the FFPE tissues.
ABSTRACT
Background Recent rapid advances in molecular biology have led the discovery of disease-specific novel fusion genes in a variety of soft tissue tumors. In this study, we attempted to detect these fusion genes using formalin-fixed paraffin-embedded (FFPE) tumor tissues and investigated their clinical utility and factors that affect the results of examination. Methods Reverse transcription polymerase chain reaction for the detection of tumor-specific fusion genes was performed using 41 FFPE tumor samples obtained from 37 patients representing nine histological types of soft tissue tumors that were diagnosed from 2006 to 2017 in our laboratory. Results Fusion genes in 19 (51.3%) out of 37 cases were detected successfully. Relatively high detection rates were observed in synovial sarcomas (100%, 4/4) and alveolar rhabdomyosarcomas (75%, 3/4). The detection rates of fusion genes were inversely correlated with the storage period of FFPE blocks. Decalcification by Plank-Rychlo solution significantly affected detection rates of the internal control gene (P = 0.0038). In contrast, there was no significant difference in detection rates between primary and metastatic lesion, or biopsy and resection material, or presence and absence of treatment history. Conclusion In certain histological types, detection of disease-specific fusion genes of soft tissue tumors using FFPE tissues showed high sensitivity and thus had diagnostic utility. However, due to the diversity of fusion patterns and the low-quality of nucleic acid, the detection rate as a whole was sluggish and required further improvement. For factors affecting the detection results, our results suggested that it was impossible to detect fusion genes by decalcified FFPE tissues, but it may be not necessary to consider factors such as the type of specimen (biopsy or resection) and treatment history of the patients when selecting the FFPE tissues.
Soft tissue tumors are a heterogeneous group of mesenchymal neoplasms which its histological assessment is challenging, as the morphology and immunoprofile of different tumor types frequently overlap, and can mimic other tumor types. So far, in the diagnosis of several sarcomas such as Ewing sarcoma or Synovial sarcoma, disease-specific fusion gene detection is useful. [1] [2] [3] [4] Currently rapid molecular biological progress discovers novel fusion genes. Clinicopathological disease units of some sarcomas have been classified based on their genetic abnormalities. 5 However, regarding the detection of translocation in such sarcomas, there are many types of translocation patterns, and optimization of standard methods for primer designs and reverse transcription polymerase chain reaction (RT-PCR) conditions have not been established, so it is not sufficiently clarified how much fusion gene detection contributes to improvement of diagnostic accuracy in the hospitals. In this study, we have searched fusion genes from soft tissue tumors, examined the diagnostic usefulness and evaluated how much it contributed to improvement of pathological diagnostic accuracy in general hospitals. At the same time, very important factors influencing detection of the fusion genes were also investigated from the standpoint of clinical laboratory technologist.
MATERIALS AND METHODS

Tumor Samples
We identified 37 cases of soft tissue tumors diagnosed between 1 April 2006 and 30 October 2017 with formalinfixed paraffin-embedded (FFPE) tissue available in 
Primers and Reverse Transcription-PCR
The primers which were designed with amplicon length of 75-160 bp and amplicon T m of 60 ± 3 °C were made using the NCBI Primer-BLAST tool (Table 2) . RNA was extracted from FFPE tissues by PureLink FFPE Total RNA Isolation Kit (Invitrogen, Waltham, MA). Total RNA from each FFPE sample was used to synthesize the first-strand cDNA using ReverTra Ace qPCR RT Master Mix with gDNA Remover (TOYOBO, Osaka, Japan). The subsequent PCR was performed in a final reaction volume of 20 µL containing 10 U TaKaRa Ex Taq Hot Start Version (TaKaRa, Shiga, Japan), 2 µL cDNA, 1 µL gene specific forward primer and reverse primer. The following PCR conditions were used an initial denaturation at 94 °C for 4 minutes 30 seconds, 40 cycles at 94 °C (30 seconds), 55 °C (30 seconds), 72 °C (30 seconds), and one final extension at 72 °C for 4 minutes 30 seconds. Because the amplified products could not be obtained in the preliminary experiment standard RT-PCR in the myxoid liposarcoma cases, semi-nested PCR method which was represented by two types forward primers (external and internal) and one type reverse primer was adopted. The amplification profile of the first-round PCR consisted of 40 cycles of denaturation at 94 °C for 4 minutes 3 seconds, annealing at 55 °C for 30 seconds, and extension at 72 °C for 4 minutes 30 seconds. The second-round PCR was 2 µL of 5-fold diluted solution of the first-round PCR product as a template with the following cycling condition: denaturation at 94 °C for 4 minutes 3 seconds, annealing at 55 °C for 30 seconds, and extension at 72 °C for 4 minutes 30 seconds. PCR products were visualized on a 2% agarose gel using ethidium bromide staining. Several cases which the amplification product could not be detected were used as designed primers for another translocation pattern. In some cases, we tried to improve the detection rate as much as possible. PCR products of several cases were sequenced with forward and reverse primers in the Applied Biosystems 3500xL Genetic Analyzer (Thermo Fisher Scientific, Waltham, MA). As a control for cDNA synthesis and sample quality, each sample was reverse transcribed and amplified for the housekeeper gene ACTB (98 bp). 6 
Statistical Analyses
Fisher's exact test (two-sided) was performed to compare categorical variables. Results were considered significant when P-values were less than 0.05. All statistical analyses were conducted using the R ver. 3.3.2.
Ethical Approval
This study has been implemented since it was approved by the Institutional Review Board of Tottori University Hospital (research management number, G179).
RESULTS
Detection Results
Of the all 37 extracted cases ( (Fig. 1) . EWSR1ex7-WT1ex8 that detected in more than 80% of cases, the most common fusion gene in one desmoplastic small round cell tumor case, 7, 8 was not detected, however we detected EWSR1ex9-WT1ex8 which was a rare translocation pattern (Fig. 2) . In an angiomatoid fibrous histiocytoma case, neither EWSR1ex7-CREB1ex7, 9, 10 EWSR1ex7-ATF1ex5 9-12 nor FUSex5-ATF1ex5 13, 14 was detected. In two epithelioid hemangioendothelioma cases, no amplified products were obtained for WWTR1ex4-CAMTA1ex8 (type1) and W WTR1ex4-CAMTA1ex9 (type2).
15, 16
Affectors of Detection
Factors affecting detection of fusion genes were examined. To investigate the effects of decalcification, we selected 2 samples of Ewing sarcoma and 1 sample of myxoid liposarcoma that were decalcified FFPE samples. No amplified products either transcription or ACTB were detected in these samples (Fig. 3) . Therefore, in the subsequent examination, affectors other than decalcification were analyzed in the FFPE samples excluding the decalcified samples. FFPE tissues stored at room temperature have been used as archival resources in many molecular studies. The characteristic of FFPE samples based on storage period as follows: less than one year (11 samples), one to two years (8 samples), three to four years (9 samples), five to seven years (5 samples), and eight to eleven years (5 samples). The detection rates for fusion genes were as follows; 73% (8/11) for samples stored less than one year was positive, 63% (5/8) for samples stored one to two years was positive, 44% (4/9) for samples stored three to four years was positive, 40% (2/5) for samples stored five to seven years was positive, and 20% (1/5) for samples stored eight to eleven years. As described above, the longer the storage period, the lower the detection rates of fusion transcripts will be. Whereas the detection rates for ACTB were as follows; 100% (11/11) for samples stored less than one year was positive, 100% (8/8) for samples stored one to two years was positive, 89% (8/9) for samples stored three to four years was positive, 80% (4/5) for samples stored five to seven years was positive, and 100% (5/5) for samples stored eight to eleven years was positive. As described above, the detection rates were almost constant regardless of the storage period (Fig. 4) . There was no significant difference in the detection rates of the fusion genes and ACTB, between biopsy and resection samples (Fig. 5A) , between with and without chemoradiation treatment samples (Fig. 5B) , and between primary lesion and metastatic lesion samples (Fig. 5C ).
DISCUSSION
Even though the frequency of each histological types of soft tissue tumors are rare, there are over 100 types of histological type. 5 In addition, we recognize general histopathological diagnosis limitations, as the morphology and immunoprofile of different tumor types frequently overlap and can mimic other tumor types. Furthermore, in recent years, with advances in treatments such as chemotherapy or radiation therapy, opportunities are increasingly demanded for definite diagnosis with a sample volume in minute amounts by preoperative needle biopsy. The detection of tumor-specific fusion genes is becoming an integral part of the diagnostic investigation of soft tissue tumors. In more detail, synovial sarcoma showing from epithelial to sarcoid lesion may cause diagnostic challenges. However, detecting disease-specific fusion genes such as SYT-SSX1 or SYT- Fig. 3 . The effect of decalcification for fusion genes and ACTB detection rates. **P < 0.01. N.S., not significant SSX2 helps diagnosis of this tumor. Furthermore, in round cell sarcomas such as Ewing sarcoma or rhabdomyosarcoma, detecting the fusion genes are important for deciding course of treatment. One reason is that the patients suffering from tumors of specific subtypes of round cell sarcoma, like Ewing sarcoma or rhabdomyosarcoma, respond to well-defined therapeutic regimens. Proper classification of soft tissue tumors is crucial for appropriate patient management. In this study, we have searched fusion genes from soft tissue tumors, examined the diagnostic usefulness and evaluated how much it contributed to improvement of pathological diagnostic accuracy in general foundation hospitals. At the same time, from the standpoint of clinical laboratory technologist, we also analyzed factors influencing the detection of fusion genes.
In the cases of ACTB positive, the comprehensive detection rate was not as high as 55% (19/34 cases). It has been suggested that one of the causes could be that primers of our own design may not cover all of the fusion genes that can be expressed in our soft tissue tumor cases because there are multiple types of fusion yr, year(s).
Fig. 5.
Comparison of the detection rates of fusion genes and ACTB in each factor. N.S., not significant genes or fusion points in soft tissue tumors. Focusing on the detection rate in each histological type, favorable detection results were obtained in synovial sarcoma and alveolar rhabdomyosarcoma. Tsuji et al. reported that the frequencies of the fusion genes SYT-SSX1 and SYT-SSX2 by RT-PCR in synovial sarcomas were 73% and 24% respectively, 1 whereas PAX3-FOXO1 and PAX7-FOXO1 have been described in 55% and 22% of alveolar rhabdomyosarcomas, respectively, according to Sorensen et al. 17 These two tissue types have high detection rates because the translocation pattern is relatively limited. On the other hand, angiomatoid fibrous histiocytoma and epithelioid hemangioendothelioma prove a challenge to detect translocations from FFPE samples by our designed primers and PCR condition. The reason why a sufficient detection rate could not be obtained in these tumors may be attributable to various translocation
pattern, in addition, to the RNA ravages due to storage time in the FFPE samples. The fusion genes in 5 myxoid liposarcoma cases were not detected by standard RT-PCR in preliminary experiment. It may be affected by the low concentration of the tumor cells. However, the fusion genes in 3 out of 5 cases in myxoid liposarcoma were successfully detected by semi-nested RT-PCR. Powers et al. reported that fusion genes of myxoid liposarcoma could be efficiently detected by standard RT-PCR. 18 On the other hand, Hisaoka et al. showed that the nested RT-PCR assay could specifically detect multiple consistent fusion gene transcripts of myxoid liposarcoma generated after splicing of introns in which most of the variable breakpoints are located. 19 As described above, the fusion gene retrieval from FFPE samples of this tumor is recommended to use nested RT-PCR or semi-nested RT-PCR. In this study, fusion genes of myxoid liposarcoma could be detected sufficiently even with semi-nested RT-PCR. We searched for EWSR1-FLI1, the most common fusion variant in Ewing sarcoma cases which has two type variants: type 1 (55%) and type 2 (25%), and the second common fusion variant was EWSR1-ERG (10%). [2] [3] [4] The detection rate was 50% (2/4 cases). Next we evaluated NAB2-STAT6, the most common fusion gene variant in solitary fibrous tumor cases which had three type variants as follows: type 1 (45%), type 2 (21%), and type 3 (21%). 20 We found the detection rate for NAB2-STAT6 was 42% (5/12 cases), which was not high. The detection rate in mesenchymal chondrosarcoma cases was 50% (1/2 cases), we could not obtain adequate result. The results described above seemed also being caused by the quality of FFPE samples or the variation of the fusion genes which influenced the detection rate.
In this experiment, we adopted RT-PCR assay because Patel et al. state that RT-PCR targeting the specific fusion transcripts associated with soft tissue tumors are a valuable ancillary tool for diagnosis, 16 particularly as more soft tissue tumors are discovered to harbor recurrent translocations involving overlapping genes. They also made the cautionary comment that fluorescence in situ hybridization alone may be unsuitable for evaluating different types of tumors sharing the same gene rearrangement. 16 We examined factors that affect in the search for fusion gene using FFPE samples, and as a result, the decalcification was the most influential factor. Primary and metastatic bone tumors decalcify during tissue pathology specimen preparation process. Nam et al. showed that the PCR results were significantly affected by the decalcification time and the yield of RNA or DNA from decalcified tissues decreased gradually with increasing decalcification time. 21 Therefore, for examining fusion gene from primary and metastatic bone tumor tissues, it is necessary to selectively cut out portions which not requiring decalcification process. In addition, when selecting FFPE blocks for genetic diagnosis, it is recommended to use nondecalcified blocks.
The detection rates of fusion genes also were greatly affected by the storage period of FFPE samples. 21 In our study, even FFPE samples stored for one to two years showed lower detection rates than FFPE samples stored for less than one year, suggesting that deterioration of RNA is caused even for a storage period about one year depending on the case. Therefore, since an acceptable range was not established for the storage period of FFPE samples in which detection of the fusion gene is possible, it was considered to perform the detection as soon as possible.
We compared the detection rates of fusion genes between biopsy and resection samples, but there was no significant difference. Detection using biopsy samples could have a false negative due to lack of sample volume. However, in this study, even taken from small quantities of specimens it is suggested that detection is possible as long as tumor components are sufficiently contained. Furthermore, it is considered that RNA is not easily influenced by RNase because the biopsy materials undergo formalin fixation completely in a short time. Therefore, it is possible that excellent detection results could be obtained despite a small amount of biopsy materials. In the approximately 1-week formalin-fixed resection specimens, the detection rates were high in ACTB despite being fixed in formalin without incision. This means that the influence that the fixed condition had on fusion gene detection was minimal. According to Nam et al., when conducting a gene search study from RNA, it is recommended using 20% formalin for tissue fixation and the tissues should be immersed in formalin solution for 3 to 7 days. 21 In other words, to obtain a highly accurate result, it is important to quickly inactivate RNase in the tissue. However, large resection specimens require considerable time for completing formalin fixation step. In the fusion gene search using RT-PCR, it is recommended that a part of the tumor is collected and fixed from the surgically resected specimen before RNA is affected by RNase to ensure constant detection sensitivity.
We also examined other factors that affect detection results. When comparing the detection rates between with and without chemoradiation treatment samples, or primary lesion and metastatic lesion samples, no significant difference was observed. Metastasis and chemoradiation treatment could cause gene mutations in tumors, these factors were thought affecting the detection rate, but in this study there were no differences among these factors. This may indicate that the fusion genes are likely to be retained even in metastasis or after treatment. Therefore, it suggests that considering these factors as confounding factors in the fusion gene search might not be necessary. Our results may suggest that the soft tissue tumors are cancer stem cell derived tumors. Zhou et al. reported that the development of synovial sarcoma may arise from cancer stem cells. 22 Furthermore, cancer stem cells show resistance to chemotherapy and radiotherapy which known as the cause of recurrence and metastasis. 23 In the light of above, our findings may suggest that soft tissue tumors used in this study are tumors that originated from cancer stem cells. To the best of our knowledge, there was no literature comparing the detection rates of fusion genes which collected from various conditions samples as in our study condition. However, since we analyzed only 41 samples, we consider that further examination is necessary to get more accurate results.
The results obtained in this study, the storage periods or decalcification, were similar to the data reported by Kanai et al. 24 However, these published data do not indicate how much they can respond to the routine work in general hospitals or data comparing the detection rates between primary and metastatic lesions, biopsy and resected material, or the presence or absence of treatment history. In our study, it was indicated that the fusion genes of tumors showing relatively simple chromosomal abnormalities can be detected by selecting FFPE blocks with short-storage periods and nondecalcification even at general hospitals. Furthermore, it was indicated that factors such as biopsy or resected material, primary or metastatic lesions, or the presence or absence of treatment history may not be necessary while considering selection of FFPE blocks.
In recent years, rapidly developing genomic medicine adds consideration how to handle and manage the pathological tissue samples storage properly. The quality control of FFPE samples is important in examinations using molecular pathological methods, since numerous factors could affect the detection of fusion genes. The quality control of FFPE samples, formalin fixation and decalcification conditions are becoming the clinical laboratory technologist's responsibility who is involved in pathological examination. These parts will greatly affect gene search, therefore we need to ensure these accuracies. Even more, we consider the same importance of how to handle pathological tissue samples focusing on genetic diagnosis as well as how to handle samples for histopathological and immunohistological diagnosis. At the same time, establishing optimal fixation conditions and standardizing methods for fusion gene search are essential for improving the accuracy of molecular pathological diagnosis in pathology laboratory.
